ANDA 83799, held by Roxane. Imipramine Hydrochloride.
As of Nov 16, 2026, ANDA 83799 (Imipramine Hydrochloride), held by Roxane, was first approved by FDA on Aug 5, 1977, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 5, 1977 | Original application | Approved | None posted |
| Imipramine Hydrochloride10MG · tablet;oral | Imipramine Hydrochloride | Discontinued |
| Imipramine Hydrochloride25MG · tablet;oral | Imipramine Hydrochloride | Discontinued |
| Imipramine Hydrochloride50MG · tablet;oral | Imipramine Hydrochloride | Discontinued |
| Feb 9, 1994 | Supplement 21Labeling | Approved | None posted |
| Oct 19, 1990 | Supplement 20Labeling | Approved | None posted |
| Sep 15, 1989 | Supplement 19Labeling | Approved | None posted |
| Aug 5, 1977 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters